Form 8-K ADMA BIOLOGICS, INC. For: Apr 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
ADMA Biologics (ADMA) Promotes Kaitlin Kestenberg to COO
April 2, 2024 5:21 PM EDTEffective April 1, 2024 (the Effective Date), Kaitlin Kestenberg, former Senior Vice President, Compliance & Project Operations of ADMA Biologics (NASDAQ: ADMA), was promoted to Chief Operating Officer and Senior Vice President, Compliance of the Company (the Promotion).
... More